Natasha Persaud

Older adults and individuals with diabetes did not experience a faster decline in SARS-CoV-2 antibody titers, investigators found.

In a study, approximately one-third of patients with lupus membranous nephritis tested positive for the proteins exostosin 1/exostosin 2.

Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.

In a study, preeclampsia developed in women with LN developed 9-fold more often than women with systemic lupus erythematosus and no renal involvement.

Most patients with lupus nephritis who flared after immunosuppressant discontinuation re-achieved remission after restarting immunosuppressive therapy.

The overriding concern of vaccine-hesitant patients related to side effects, followed by doubts about the efficacy of a vaccine, and discomfort with vaccines in general, according to investigators.

Researchers studied the clinical features, treatment modalities, and long-term renal outcomes of pediatric patients with lupus nephritis.

Lupus nephritis recurrences, while rare, typically happen within a few years of kidney transplantation.

Investigators stress the importance of smoking cessation in patients with systemic lupus erythematosus, particularly among those carrying particular risk alleles.

In a small study, 25% of adults with COVID-19 shed SARS-CoV-2 spike S1 protein in their urine at least once during the course of infection.

Patient characteristics, such as dialysis use and diabetes status, appeared to be influential factors.

This the first study to evaluate the risk for venous thromboembolism by lupus nephritis class, according to investigators.

A comprehensive meta-analysis quantified the risks of several cardiovascular diseases in patients with systemic lupus erythematosus (SLE).

CD62L, a basophil activation marker, may be a noninvasive prognostic biomarker that can be used to treat patients with severe lupus nephritis.

Bone loss in patients with kidney stone disease, particularly in men, has been underappreciated in clinical practice, according to investigators.

Study findings support the utility of the 2019 EULAR/ACR classification in everyday nephrology clinical practice.

Despite the disappointing results of randomized controlled trials such as LUNAR, targeting B cells remains an attractive option in patients with lupus nephritis.

Over 20 years, 8.4% of patients with lupus developed end-stage kidney disease, a study found.

Investigators performed post hoc analyses of the CKD-FIX trial, stratifying patients by their CKD stage and serum urate level at baseline.

In contrast to CARES, FAST found that treatment with febuxostat was not associated with an increase in cardiovascular or all-cause death compared with allopurinol in patients with gout.

Fracture prevention efforts should be considered in patients with CKD of any age, according to investigators.

Among individuals with chronic kidney disease, the presence of anemia doubled the risk for hyperuricemia.

Gout that develops in kidney transplant recipients increases their risk of worse outcomes, according to 2 new studies.

There is increasing evidence to support lower serum uric acid thresholds of at least 6 mg/dL in patients with gout to improve survival.